Elevated levels of plasminogen activator inhibitor type-1 (PAI-1) are linked to increased risk of AS, thrombosis, and other CVDs due to its ability to regulate the fibrinolytic system and inhibit the breakdown of blood clots [132]. Here, SERPINE1 is linked to Venous thrombosis.